In Brief
In autophagy, the adaptor protein p62/SQSTM1 selectively sequesters ubiquitinated protein aggregates into inclusion bodies and recruits them to the growing autophagosome. Lee et al. show that ubiquitination of p62 within its ubiquitin-binding UBA domain enhances p62's sequestering activity and autophagic degradation.
INTRODUCTION
Autophagic degradation can be a selective process targeting distinct cargoes via autophagic receptor proteins (Rogov et al., 2014) . p62/SQSTM1 (p62) is an autophagic receptor that interacts with ubiquitinated cargo via its ubiquitin association (UBA) domain and recruits them via its LC3-interacting motif into the growing autophagosome membrane (Bjørkøy et al., 2005; Komatsu et al., 2007; Pankiv et al., 2007) . Autophagic degradation of ubiquitinated proteins requires p62 to sequester them into inclusion bodies. This property is mediated by p62's UBA domain but also via a PB1 domain that facilitates homo-oligomerization (Bjørkøy et al., 2005; Ciuffa et al., 2015; Itakura and Mizushima, 2011) .
The oligomerization of p62 may serve several different roles in both inclusion body formation and autophagy. For example, p62 oligomers may organize along with ubiquitinated proteins, sequestering them into inclusions (Bjørkøy et al., 2005) . In addition, p62 forms filamentous structures via its PB1 domain that may serve as a site for phagophore membrane development (Itakura and Mizushima, 2011) . Interestingly, p62 filaments are fragmented in the presence of polyubiquitin (Ciuffa et al., 2015) . This fragmentation is mediated via p62's UBA domain and suggests that higher-ordered oligomeric p62 structures may dynamically change in the setting of ubiquitin.
Consistent with p62's role in the handling of ubiquitinated protein aggregates, dominantly inherited missense or deletion mutations within p62's UBA domain are associated with degenerative diseases, including Paget's disease of the bone (PDB), amyotrophic lateral sclerosis (ALS), fronto-temporal dementia, and, more recently, inclusion body myopathy (Bucelli et al., 2015; Rea et al., 2014) . The common pathogenic feature among these disparate tissues is the accumulation of p62 aggregates and ubiquitinated inclusions. How p62 mutations contribute to disease pathogenesis is unclear but may relate to diminished ubiquitin binding activity (Layfield et al., 2006) .
The post-translational modification of p62 has been demonstrated to regulate its function. Phosphorylation at one of two different serines within p62's UBA domain enhances its association with ubiquitinated proteins, promoting sequestering activity and rescue from proteotoxic stress (Lim et al., 2015; Matsumoto et al., 2011) . Ubiquitination of p62 also occurs. Mass spectrometry approaches have identified multiple ubiquitination sites on p62 that include lysine residues within the PB1 and UBA domains (Kim et al., 2011; Song et al., 2016) .
Ubiquitination of p62 can also modulate its function. Recently, studies identified ubiquitin ligases that, depending upon their site of ubiquitination, inhibited or facilitated p62's function (Heath et al., 2016; Jongsma et al., 2016; Pan et al., 2016) . The E3 ubiquitin ligase TRIM21 ubiquitylates p62 at lysine 7 within its PB1 domain. This ubiquitination abrogates p62 oligomerization, thus inhibiting p62's sequestration activity (Pan et al., 2016) . p62 is also ubiquitinated within its UBA domain by the E3 ligase RNF26, although the exact residue in the UBA domain was not determined. This ubiquitination event was proposed to enhance p62's interaction with other ubiquitin adaptors such as TOLLIP, thus facilitating vesicular cargo sorting (Jongsma et al., 2016) . In addition, RNF166 ubiquitinates p62 at residues K91 and K189 (Heath et al., 2016) . Interestingly, these events involve atypical ubiquitin chains that are K29-and K33-linked. RNF166-mediated ubiquitin ligase activity facilitates p62's role in the xenophagic degradation of intracellular bacteria (Heath et al., 2016) .
p62 also associates with E3 ligases to regulate cell signaling pathways. Keap1 is an E3 ligase adaptor that contains a BR-C, ttk and bab (BTB) domain at its N terminus, which mediates interaction with Cullin3 (Cul3) (Furukawa and Xiong, 2005) . One substrate of the Keap1/Cul3 complex is Nrf2. When Keap1 is destabilized by oxidative stress, Nrf2 stabilizes and translocates to the nucleus, where it activates the expression of genes regulated by antioxidant response elements (Kobayashi et al., 2006 ). Several studies demonstrate that p62 binds to Keap1, sequestering it into aggregates under conditions of autophagic inhibition (Ichimura et al., 2013; Komatsu et al., 2010; Lau et al., 2010) . This p62-Keap1 interaction titrates Keap1 away from Nrf2, stabilizing Nrf2 by decreasing Cul3-mediated ubiquitination and allowing Nrf2-mediated activation of the antioxidant response pathway.
In this study, we find that p62 is ubiquitinated at lysine 420 within its UBA domain. This ubiquitination is mediated by the Keap1/Cul3 E3 ligase complex. Moreover, mutation of lysine 420 or disease mutations within p62's UBA domain affect its ubiquitination and diminish its sequestration activity. The ubiquitination of ubiquitin binding proteins such as p62 is emerging as an important regulatory mechanism for autophagic adaptor proteins.
RESULTS
p62's UBA Domain Is Ubiquitinated at K420 p62 associates with ubiquitinated proteins in cells (Bjørkøy et al., 2005) . We co-expressed HA-p62 and FLAG-ubiquitin (FLAG-Ub) in p62 À/À mouse embryonic fibroblasts (MEFs) for 24 hr and then immunoprecipitated with a hemagglutinin (HA) antibody. Both p62 and FLAG-Ub were detected within the immunoprecipitate ( Figure 1A ). Interestingly, although FLAG-Ub migrated as a high-molecular-weight (HMW) species in the cell lysate, it migrated at $75 kDa in the HA immunoprecipitant ( Figure 1A) . Moreover, an immunoblot of p62 from similar lysates demonstrated both a 65-kDa band and several HMW species (Figure 1A) . These data suggested that FLAG-Ub was conjugated to p62. Treatment of cell lysates with the catalytic domain of ubiquitin-specific protease 2 (Usp2cc) collapsed the HMW species above p62 and abolished the presence of FLAG-Ub within the HA immunoprecipitant ( Figure 1A ). N-ethylmaleimide (NEM) increased the amount of ubiquitinated p62 and inhibited the effect of Usp2cc ( Figure 1A ). We co-expressed both FLAG-Ub and an HA-p62 construct that lacks its UBA domain, p62-DUBA, and immunoprecipitated with an antibody to HA in p62 À/À MEFs. p62-DUBA failed to coimmunoprecipitate any FLAG-Ub, even in the presence of NEM ( Figure 1B) . A similar experiment was performed that co-expressed FLAG-Ub and an HA-p62 construct that lacks its N-terminal PB1 domain, p62-DPB1. Similar to p62-DUBA, p62-DPB1 failed to co-immunoprecipitate any FLAG-Ub ( Figure 1C ). To see whether this was related to a lack of a critical lysine residue such as K7 or K13, which have been reported previously to be ubiquitinated, or related to a lack of p62 dimerization, which is mediated via the PB1 domain, we performed the same experiment with HA-p62-D69A, which fails to dimerize but maintains all N-terminal lysines ( Figure 1D ; Pan et al., 2016; Song et al., 2016) . Again, similar to p62-DPB1, no FLAG-Ub was immunoprecipitated, suggesting that the dimerization of p62 may be critical for the ubiquitination of p62's C-terminal region.
To identify the principal lysine that is ubiquitinated on p62, we selected seven sites determined by mass spectrometry analysis and previous proteomic studies (Kim et al., 2011; Mertins et al., 2013; Song et al., 2016; Wagner et al., 2011) . We generated multiple HA-p62 mutant constructs with a lysine-to-arginine substitution (K/R; Figure S1 ). Notably, the HA tag does not contain a lysine. HA-p62 constructs were co-transfected with FLAG-Ub into p62 À/À MEFs for 24 hr and then immunoprecipitated with HA antibody in the presence of NEM. Mutation of all selected lysines, HA-p62-7K/R, abolished the ubiquitination of p62, as seen by the absence of FLAG-Ub in the immunoprecipitant ( Figure 1E ). However, immunoprecipitation of p62 with mutations of six lysine residues (HA-p62-6K/R), which retain the C-terminal K420 residue, demonstrates FLAG-Ub in a pattern similar to p62 wild-type (WT) ( Figure 1E ). Changing the lysine at amino acid 420 to an arginine (HA-p62-K420R) diminished the amount of FLAG-Ub in the immunoprecipitant, similar to HA-p62-DUBA expression, suggesting that the principal ubiquitinated lysine resides at K420 ( Figure 1E ). To confirm that ubiquitin was indeed covalently attached to p62, we co-transfected HA-p62-WT, HA-p62-K420R, or p62-DUBA with histidine-tagged ubiquitin (His-Ub) into p62 À/À MEFs for 24 hr and performed purification using a nickel-charged affinity resin in the presence of 6M guanidine. Consistent with our results in radioimmunoprecipitation assay (RIPA) buffer, only HMW HA-p62-WT was present in the affinity-purified lysate ( Figure 1F ).
p62's UBA Domain Is Ubiquitinated by Keap1/Cul3 Because p62 interacts with Keap1, an adaptor for the E3 ligase Cul3, we expressed HA-p62-WT, HA-p62-K420R, and HA-p62-DUBA with FLAG-Ub and Myc-Cul3 in p62 À/À MEFs ( Figure 2A ; Komatsu et al., 2010) . After 24 hr, immunoblotting for p62 demonstrated an increase in ubiquitinated p62 in Myc-Cul3-expressing cells, as evidenced by an increase in HMW p62 bands that were not present in HA-p62-K420R-or HA-p62-DUBA-expressing lysates ( Figure 2A ). To further demonstrate that p62 could be ubiquitinated by Cul3, we transfected p62 À/À MEFs with an expression construct containing a FLAG-tagged Cul3-WT or an inactive Cul3 that lacks its C terminus (Cul3-DN) and immunoprecipitated Cul3 with an anti-FLAG antibody. Purified His-p62 lacking the first 84 amino acids of p62, which does not contain two previously reported ubiquitination sites on p62 adjacent to the PB1 domain (K7 or K13), was incubated with ubiquitin, immunoprecipitated FLAG-Cul3, and recombinant E1/E2 enzymes. Consistent with His-p62 ubiquitination, there was an increase in its molecular weight when FLAG-Cul3-WT and not FLAG-Cul3-DN (dominant negative) was included in the reaction ( Figure 2B ). To function in ubiquitination reactions, Cul3 must be activated by, and bound to, NEDD8 in a process called neddylation (Singer et al., 1999) . Cul3 activity can be inhibited using a nonspecific neddylation inhibitor, MLN4924 (Soucy et al., 2009) abolished p62 ubiquitination, as assessed by FLAG immunoblot ( Figure 2C ). Because p62 associates with Keap1, an adaptor of the Cul3 ligase complex, we reasoned that p62 ubiquitination may be diminished in the absence of Keap1. We expressed HA-p62 and FLAG-Ub in Keap1
À/À MEFs with or without Myc-Keap1
for 24 hr and immunoprecipitated the lysates with an HA antibody. The amount of ubiquitinated p62 was increased when Myc-Keap1 was expressed in Keap1 À/À MEFs ( Figure 3A ).
Immunoprecipitation of HA-p62 in p62 À/À MEFs expressing FLAG-Ub, V5-Cul3, and Myc-Keap1 demonstrated more ubiquitinated p62 compared with expression of HA-p62 and FLAG-Ub alone ( Figure 3B ). This ubiquitination was abrogated when MycKeap1-DBTB, which lacks its BTB domain, which is necessary for Cul3 association, was expressed along with V5-Cul3, further suggesting that the Keap1/Cul3 complex mediates ubiquitination of p62 ( Figure 3B ). p62 binds to Keap1 via its Keap1-interacting region (KIR). A single point mutation in p62, T350A, abolishes this interaction (Komatsu et al., 2010) . To further establish that p62 ubiquitination is facilitated via Keap1, we expressed HA-p62-WT, HA-p62-T350A, or HA-p62-DUBA along with FLAG-Ub in Keap1
À/À MEFs with or without Myc-Keap1 for 24 hr and immunoprecipitated the lysates with an HA antibody. Although Myc-Keap1 co-expression increased ubiquitinated HA-p62-WT, as detected by FLAG antibody, there was no augmentation of HA-p62-T350A when Myc-Keap1 was also expressed ( Figure 3C ). Because the previous studies used an overexpressed human p62 construct in knockout mouse cells (see Figure S1B for the level of overexpression compared with control lines), we wanted to establish that endogenous p62 was indeed ubiquitinated. To do this, we expressed His-Ub in U20S cells treated with vehicle or MLN4924 for 24 hr and performed purification using a nickelcharged affinity resin in the presence of 6M guanidine. Immunoblotting of the purified lysate with an antibody to p62 demonstrated an HMW smear in His-Ub-transfected cells that was reduced when MLN4924 was added to the cells ( Figure 3D ). Similarly, we expressed Myc-Keap1 and V5-Cul3 in U20S cells or treated these cells with MLN4924. Lysates were then immunoblotted with a polyclonal antibody to p62. Myc-Keap1/V5-Cul3 co-expression increased the amount of a second band migrating above p62, and this band disappeared with MLN4924 treatment ( Figure 3E ).
UBA Domain Ubiquitination Enhances p62's
Sequestering Activity p62's sequestering activity is required for ubiquitinated inclusion body formation in the setting of autophagic impairment, and loss of p62 leads to a reduction of insoluble ubiquitinated proteins with a concomitant accumulation of soluble ubiquitinated proteins (Komatsu et al., 2007) . To explore this function, we expressed a control vector, HA-p62-WT, HA-p62-K420R, and HA-p62-DUBA in p62 À/À MEFs and fractionated cell lysates via ultracentrifugation ( Figure 4A ). In the absence of p62, ubiquitinated proteins remain in the supernatant and do not shift to the pelleted fraction. HA-p62-WT was enriched in the pelleted fraction along with HMW ubiquitinated proteins. In contrast, HA-p62-K420R and HA-p62-DUBA were enriched in the supernatant fraction and did not shift ubiquitinated proteins to the pelleted fraction. Expression of HA-p62-WT in p62 À/À MEFs generated multiple punctate ubiquitin-positive inclusions throughout the cytoplasm. In contrast, HA-p62-DUBA and HA-p62-K420R had markedly fewer ubiquitin-positive inclusions ( Figures 4B and 4C ). Co-expression of Myc-Keap1, V5-Cul3, or Myc-Keap1/V5-Cul3 increased the percentage of HA-p62-WT-expressing cells containing ubiquitinated aggregates, which did not occur in cells expressing HA-p62-K420R ( Figure 4B ; Figure S2 ). Similarly, we expressed mCherry-p62-WT and mCherry-p62-K420R in p62 À/À MEFs or ATG5 À/À MEFs and quantitated the average size of p62 bodies. mCherry-p62-WT formed larger p62 bodies, and this was greater in ATG5 À/À MEFs ( Figures 4D and 4E ). Coexpression of Myc-Keap1/V5-Cul3 further increased mCherryp62-WT body size in both cell types, but mCherry-p62-WT body size did not increase when Myc-Keap1-DBTB/V5-Cul3 were co-expressed. In control fibroblasts, co-expression of MycKeap1/V5-Cul3 increased mCherry-p62-WT body size, but this augmentation did not occur with mCherry-p62-T350A expression ( Figure 4F ). Co-expression of Myc-Keap1/V5-Cul3 increased the size of endogenous p62 bodies, and MLN4924 treatment significantly decreased the size in U20S cells ( Figure S3 ). mCherry-p62-WT or p62-K420R was expressed in p62
MEFs, and live-cell imaging was performed to evaluate fluorescence recovery after photobleaching (FRAP) of individual puncta. The initial rapid phase of recovery has been suggested to correlate with p62's sequestering activity (Matsumoto et al., 2011) . The fluorescence exchange rate of mCherry-p62-K420R was more rapid than that of mCherry-p62-WT, and co-expression of Myc-Keap1/V5-Cul3 decreased fluorescence recovery, whereas co-expression of Myc-Keap1-DBTB/V5-Cul3 increased fluorescence recovery (Figures 5A and 5B) . In a similar experiment, co-expression of Myc-Keap1/V5-Cul3 failed to decrease the fluorescence recovery of mCherry-p62-T350A ( Figure 5C ). The differences in fluorescent recovery were not due to p62 presence within an autophagosome because an experiment performed in ATG5 À/À MEFs gave similar results ( Figures S4A and S4B ).
UBA Domain Ubiquitination Increases p62 Degradation
We reasoned that the increased p62 exchange rate seen with mCherry-p62-K420R compared with mCherry-p62-WT may reduce phagophore association with p62. To test this, we expressed HA-p62-WT or HA-p62-K420R with FLAG-Ub in p62 À/À MEFs for 24 hr. Cell lysates were immunoprecipitated with an anti-HA antibody and immunoblotted for HA and LC3B. HA-p62-K420R immunoprecipitants had less LC3BII compared with HA-p62-WT ( Figure 6A ). Consistent with this, cell lysates immunoprecipitated with anti-HA from p62 À/À MEFs expressing HA-p62-WT with FLAG-Ub, Myc-Keap1, and V5-Cul3 in p62 À/À MEFs had an increase in LC3BII association, as observed on immunoblots probed with HA and LC3 (Figure 6B) . Similarly, although Myc-Keap1/V5-Cul3 co-expression increased HA-p62-WT association with LC3B, this was not seen for HA-p62-T350A ( Figure 3C ). To further explore the role of UBA domain ubiquitination by Keap1/Cul3 on p62's degradation, we expressed (legend continued on next page) tandem-tagged mCherry-GFP-p62-WT in p62 À/À MEFs for 24 hr with and without Bafilomycin A (BafA) ( Figure 6C ). When mCherry-GFP-p62-WT is in the cytosol as an inclusion body or within the non-acidic environment of an autophagosome, both mCherry and GFP fluorescence are present (Pankiv et al., 2007) . However, when mCherry-GFP-p62-WT enters an acidic environment such as an autolysosome, GFP fluorescence quenches, leaving only mCherry fluorescence. Consistent with this, the degree of mCherry:GFP co-localization was increased in BafA-treated cells compared with untreated cells ( Figure 6C ; Figures S5A and S5B ). In addition, co-expression of MycKeap1/V5-Cul3 with mCherry-GFP-p62-WT decreased the degree of mCherry:GFP co-localization, suggesting that p62 ubiquitination enhances its autophagic degradation ( Figure 6C ). This effect was not seen in the presence of BafA. The ratio of mCherry:GFP co-localization in p62 À/À MEFs expressing mCherry-GFP-p62-K420R or mCherry-GFP-p62-T350A was significantly increased compared with mCherry-GFP-p62-WT, suggesting that fewer p62-K420R or p62-T350A puncta were within autolysosomes ( Figure 6C ). In contrast to mCherry-GFP-p62-WT puncta, there was no decrease in mCherry:GFP co-localization with Myc-Keap1/V5-Cul3 expression in mCherry-GFP-p62-K420R-or mCherry-GFP-p62-T350A-expressing p62 À/À MEFs ( Figure 6C ).
We reasoned that the increase in mCherry:GFP co-localization in p62
À/À MEFs expressing mCherry-GFP-p62-K420R or mCherry-GFP-p62-T350A was due to its cytoplasmic accumulation in inclusion bodies rather than accumulation within autophagosomes. Consistent with this, p62 À/À MEFs expressing mCherry-p62-K420R or mCherry-p62-T350A had a reduction in co-localization with co-expressed GFP-LC3B compared with mCherry-p62-WT-expressing p62 À/À MEFs ( Figure 6D ).
Moreover, expression of Myc-Keap1/V5-Cul3 increased the GFP-LC3B or endogenous LC3B co-localization with mCherryp62-WT but failed to do so in mCherry-p62-K420R-or mCherry-p62-T350A-expressing p62 À/À MEFs ( Figure 6D ; Figure S5C ). Further studies demonstrated that the stability of endogenous p62 was increased in Keap1 À/À MEFs compared with control MEFs when cell lysates were immunoblotted for p62 from cells treated with cycloheximide for varying times ( Figure 6E ). This increase in p62 stability was abrogated in Keap1 À/À MEFs that were transfected with Myc-Keap1/V5-Cul3 expression constructs. The expression of HttQ72-CFP in p62 À/À MEFs is toxic, with only $5% of transfected cells remaining viable 24 hr after transfection ( Figure 6F ). This toxicity is rescued when HA-p62-WT is expressed but not by HA-p62-K420R, HA-p62-DUBA, or HA-p62-T350A ( Figure 6F ). The expression of Myc-Keap1 and/or V5-Cul3 without HA-p62-WT in p62 À/À MEFs did not significantly change HttQ72-CFP toxicity. However, co-expression of MycKeap1/V5-Cul3 along with HA-p62-WT enhanced cell viability. This effect was not seen in the setting of HA-p62-K420R, HA-p62-DUBA, or HA-p62-T350A ( Figure 6F ).
UBA Domain Ubiquitination in p62 Is Diminished with Disease Mutations
Some p62 disease mutations reside within its UBA domain ( Figure 1C ; Rea et al., 2014) . We expressed HA-p62-WT, p62-K420R, and five different disease mutations, p62-A390X (equivalent to p62-DUBA used above), p62-P392L, p62-M404V, p62-G411S, and p62-G425R along with FLAG-Ub in p62 À/À MEFs ( Figure 7A ). After 24 hr, we immunoprecipitated cell lysates with an HA antibody and immunoblotted for FLAG and HA. Immunoprecipitants from HA-p62-WT, but not HA-p62-K420R or HA-p62-A390X, had FLAG-immunoreactive bands ( Figure 7A ). In addition, all expressed p62 disease mutants showed an absence or reduction in FLAG immunoreactivity ( Figure 7A ). FRAP analysis of mCherry-p62-WT, p62-P392L, p62-M404V, p62-G411S, or p62-G425R in p62 À/À MEFs demonstrated that fluorescence recovery was more rapid with all disease mutants compared with mCherry-p62-WT ( Figure 7B ; Figure S6 ). HA-p62-WT increased the number of live cells expressing HttQ72-CFP, and this was augmented with co-expression of Keap1/Cul3 in p62 À/À MEFs ( Figure 7C ). Expression of p62 disease mutants, with the exception of HA-p62-P392L, significantly decreased cell viability compared with HA-p62-WT. Co-expression of Keap1/Cul3 in p62 disease mutantexpressing cells reduced cell death.
DISCUSSION
The present study finds that p62 is ubiquitinated at a highly conserved lysine within its UBA domain (K420) by Keap1/Cul3. Substitution of K420 to arginine, deletion of the UBA domain, or mutation of the KIR domain in p62 decreases ubiquitinated inclusion formation, its LC3 interaction, and cell viability. In contrast, Keap1/Cul3 expression can increase ubiquitinated inclusion formation and p62 inclusion body size and rescue cells from proteotoxic stress. Moreover, Keap1/Cul3 increases p62's association with LC3B and its subsequent degradation. We propose that the ubiquitination of p62's UBA domain by Keap1/Cul3 enhances its sequestration activity, subsequent phagophore association, and degradation. The molecular assembly of p62 oligomers is necessary for its function in autophagy. How this assembly is regulated is not fully understood. Recent studies support a model where the self-association of p62 occurs via its PB1 domain (Ciuffa et al., 2015) . (F) Quantitation of p62 body size in MEFs expressing mCherry-tagged p62-WT or p62-T350A with or without myc-Keap1/V5-cul3. All data are represented as mean ± SEM. *p < 0.05.
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This interaction is a nidus for the extension of a filamentous p62 scaffold that allows the engulfing phagophore membrane to bind the LC3 interacting region (LIR) domain and degrade ubiquitinated proteins (Itakura and Mizushima, 2011) . Deletion of the PB1 domain abrogates the self-association of p62, reducing p62's sequestration activity and cellular function (Bjørkøy et al., 2005) . Similarly, deletion of p62's UBA domain impairs p62 body formation even in the setting of an intact PB1 domain. p62's UBA domain can also self-associate as a dimer (Long et al., 2010) . Phosphorylation of serines 403 and 409 within the UBA domain destabilizes this dimer and regulates p62's activity (Lim et al., 2015; Matsumoto et al., 2011) . These studies suggest that p62's molecular assembly is dependent upon both its PB1 and UBA domains. The UBA domain of p62 has a shared interface that mediates dimerization and ubiquitin binding. Ubiquitin binding and UBA domain dimerization are mutually exclusive, with dimerization ''inactivating'' ubiquitin binding (Long et al., 2010) . Amino acid K420 resides at the C terminus of helix 2. Structural studies have demonstrated that this region of p62's UBA domain interacts with residues in loop 1. Indeed, point mutations in loop 1 residues (E409K and G410K) or helix 2 (T419K) disrupt dimerization (Long et al., 2010) . Whether ubiquitination of K420 disrupts dimerization, allowing increased ubiquitin binding, is unclear. Alternatively, K420 ubiquitination may serve as a means for increased oligomer formation via interaction of a p62 UBA domain with an adjacent p62 ubiquitinated UBA domain or interactions with other proteins harboring ubiquitin-binding motifs.
More recently, it was demonstrated that polyubiquitin could fragment p62 filaments, suggesting that the oligomeric structure of p62 was dynamic and could change with the addition of ubiquitinated cargo (Ciuffa et al., 2015) . Our data extend this model and suggest that the ubiquitination status of p62's UBA domain may alter p62's oligomeric structure, thus promoting inclusion body formation. This higher-ordered p62 oligomer would then further promote p62's sequestration activity, subsequent phagophore assembly, and autophagic degradation. We suggest that, by refining p62's oligomeric structure via UBA domain ubiquitination, autophagic degradation and sequestration activity can be activated or inhibited locally within the p62 inclusion body.
The ubiquitination of autophagic adaptors is emerging as a means of regulating their function. Ubiquitination of optineurin by HACE1 increases its association with p62, enhancing autophagic flux and suppressing tumor growth (Liu et al., 2014) . TRIM21 ubiquitinates p62 on its N-terminal PB1 domain, inhibiting p62 oligomerization and sequestration activity (Pan et al., 2016) . This event would antagonize Keap1/Cul3-mediated ubiquitination at the C-terminal UBA domain, suggesting that the ubiquitination of p62 can both positively and negatively affect its sequestration function. Recently, the E3 ligase RPN26 was found to recruit and ubiquitinate p62's UBA domain at the endoplasmic reticulum (ER) membrane (Jongsma et al., 2016) . This event enhanced p62's ability to capture a subset of endosomes via binding to ubiquitin binding domains on endocytic adaptors. It has not been established whether RPN26 ubiquitinates K420 or another lysine within the UBA.
Previous studies have found that a Keap1 homodimer binds to two sites on Nrf2, facilitating Cul3-mediated ubiquitination. Oxidative stress destabilizes Keap1 and abrogates it interactions with Nrf2. Keap1 binds p62 at a single KIR domain. The affinity for this interaction becomes greater as p62 accumulates under conditions of impaired autophagy, sequestering Keap1 from Nrf2, leading to its stabilization (Jain et al., 2010; Komatsu et al., 2010; Lau et al., 2010) . Similarly, Keap1 accumulates under conditions of impaired autophagy or in the setting of p62 knockdown (Lau et al., 2013) . Autophagic degradation of Keap1 through its interaction with p62 may help to maintain redox homeostasis (Watanabe et al., 2012) . In fact, Keap1 itself enhances p62-mediated ubiquitin aggregate clearance (Fan et al., 2010) . This may further serve to regulate Keap1 levels and its interactions with both Nrf2 and p62.
Our data suggest that Keap1/Cul3 can ubiquitinate p62 and enhance its autophagic activity. Only dimeric p62 is able to be ubiquitinated because p62 with a PB1 domain deletion and p62-D69A fail to be ubiquitinated ( Figures 1C and 1D ). This would suggest that a Keap1 homodimer binds to two high-affinity KIR motifs on a p62 dimer, leading to its ubiquitination. This model is similar to alternative models of Keap1, which suggests that a homodimer can associate with two Nrf2 molecules or with Nrf2 and a second protein with a KIR motif, such as PGAM5, which then targets this complex to the mitochondria . Interestingly, loss of Keap1 stabilizes p62, whereas increased expression of Keap1/Cul3 increases p62 inclusion formation and subsequent degradation. Whether Keap1 is further degraded along with p62 is not known. However, Keap1/Cul3-mediated ubiquitination and subsequent enhancement of p62 degradation would be an efficient means by which Keap1 could decrease the levels of p62, thus releasing its antagonistic interaction.
Dominantly inherited mutations in p62 are associated with several degenerative diseases ranging from PDB to ALS (Rea et al., 2014) . More recently, homozygous loss-of-function mutations in p62 were identified in patients with childhood-onset neurodegeneration (Haack et al., 2016) . Some p62 disease mutations reside within or lead to premature truncations of the UBA domain (Rea et al., 2014) . One unifying feature for these mutations is variable degrees of impaired ubiquitin binding in vitro (Layfield et al., 2006) . Our data find that UBA domain-associated p62 disease mutations also have a reduction in UBA domain ubiquitination. More recently, several p62 missense mutations associated with PDB and ALS have been identified within the Keap1-interacting region (Goode et al., 2016b; Wright et al., 2013) . These mutations lead to a loss of Keap1 interaction and a reduction in Nrf2 signaling. It is intriguing to speculate that these mutations may also affect Keap1/Cul3-associated ubiquitination of p62's UBA domain, further unifying the pathogenic mechanism of p62 mutations. Alternatively, xenophagy-associated phosphorylation of p62 at serine 349 can be disrupted by a point mutation within the UBA domain that diminishes its ubiquitin binding function (Ishimura et al., 2014) . The phosphorylation of serine 349 on p62 then increases p62's affinity for Keap1 (Ichimura et al., 2013) . It is also conceivable that UBA domainassociated disease mutations in p62 affect serine 349 phosphorylation, abrogating Keap1/Cul3-mediated ubiquitination of the UBA domain. The modulation of p62 activity via Keap1/Cul3 is an attractive therapeutic target. Expression of Keap1/Cul3 increases p62's sequestration activity. In the case of p62-associated disease mutations, Keap1/Cul3 expression restored p62's cytoprotective role in polyglutamine toxicity. Whether Keap1/Cul3-mediated ubiquitination of p62 further enhances the sequestration of Keap1, resulting in the non-canonical activation of Nrf2, which may further enhance cell viability, remains to be established. Indeed, activation of Nrf2 is cytoprotective in models of polyglutamine toxicity (Gan and Johnson, 2014) . Our present data further connect p62-mediated autophagy with the Keap1-Nrf2 signaling pathway.
EXPERIMENTAL PROCEDURES
Immunoprecipitation and Western Blotting Cells were harvested in NP-40 lysis buffer (50 mM Tris [pH 7.7] , 150 mM NaCl, and 1% NP-40) or RIPA buffer (50 mM Tris [pH 7.7] , 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS) with protease inhibitor cocktails (PICs) (Sigma, #P8340), 20 mM NEM, and PMSF (Sigma, #P7626) and washed with ice-chilled PBS. Lysates were centrifuged for 15 min at 4 C and 16,000 3 g. The supernatants were collected. Some lysates were incubated with Usp2cc (1 mg Usp2cc per 100 mg cell lysates; R&D Systems, #O75604). 200 mg of cell lysates were pre-cleared for 1 hr with end-over-end rotation with 10 mg of Dynabeads M-270 epoxy (Life Technologies, #14302D) at 4 C.
Samples were placed on a magnet, and the supernatants were collected. The supernatants were incubated with antibody-conjugated Dynabeads on the rotator at 4 C for 2 hr. For antibody conjugation, dialyzed antibodies were coupled to Dynabeads M-270 epoxy beads (Life Technologies, #14311D) according to the manufacturer's instructions. After 2-hr incubation, the samples were placed on the magnet and washed three times with lysis buffer.
In the case of denaturing conditions, the assay was performed as described previously (Pan et al., 2016) . Briefly, 10% of samples were kept as ''input'' samples. The rest of the samples were mixed with an equal volume of 6M guanidine buffer (6M guanidine-HCl, 100 mM sodium phosphate, 600 mM NaCl, 30 mM imidazole, and 0.05% Tween 20 [pH 8.0]). The mixed samples were pre-cleared for 1 hr on an end-over-end rotator with 10 mg of Dynabeads M-270 epoxy at 4 C. The samples were placed on a magnetic stand, and the supernatants were collected. The supernatants were incubated with HisPur nickel-nitrilotriacetic acid (Ni-NTA) magnetic beads (Thermo Scientific, #88831) on the rotator for 2 hr at 4 C. The samples were placed on a magnetic stand and washed twice with 8 M urea buffer (8 M urea, 100 mM sodium phosphate, 10 mM Tris-Base, and 50 mM imidazole [pH 8.0]). After all urea buffer was completely removed, the samples containing beads were incubated with elution buffer (250 mM imidazole, 100 mM sodium phosphate, and 600 mM NaCl) for 30 min on a rotator. The samples were mixed with b-mercaptoethanol-containing sample buffer and boiled at 95 C for 5 min. The western blot analysis was performed as described previously (Weihl et al., 2006) .
In Vitro Ubiquitination Assay
Recombinant E2 enzyme (UbcH5a/UBE2D1, #E2-616) and the ubiquitylation kit containing E1 enzyme (#K-995) were purchased from Boston Biochem. The recombinant fragment of histidine-tagged human p62 (#p62-29505TH) containing amino acids 83-440 was purchased from Biomart. Cells were transfected with Cul3 WT-FLAG or Cul3-DN-FLAG. 24 hr later, cells were harvested in RIPA buffer and immunoprecipitated with FLAG antibody-conjugated Dynabeads for 2 hr at 4 C. The samples were washed three times with lysis buffer and incubated with E1, E2, ubiquitin, and His-p62 (500 ng) at 37 C for 1 hr. The samples were mixed with b-mercaptoethanol-containing sample buffer and boiled at 95 C for 5 min.
Fractionation Assay p62 À/À MEFs were grown in 10-cm dishes at $80% confluency. After three washes with ice-chilled PBS, cells were harvested in RIPA buffer with PIC, PMSF, and NEM. The cells were sonicated twice for 10 s at 4 C. 10% of the sample was taken from the lysate as a ''total'' fraction. The remaining sample was centrifuged at 100,000 3 g for 30 min at 4 C. After centrifugation, the supernatant was transferred to a new tube and labeled as a ''supernatant'' fraction. The rest of sample was resuspended in 200 mL of 7 M urea buffer (7 M urea, 2 M thiourea, 4% (3-((3-cholamidopropyl) dimethylammonio)-1-propanesulfonate) (CHAPS), and 30 mM Tris [pH 8.5]) and re-sonicated for twice for 10 s at 4 C. The samples were re-centrifuged at 100,000 3 g for 30 min at 4 C. The supernatant was transferred to a new tube and labeled as a ''pellet'' fraction, and the debris was discarded.
Cell Viability Assay p62 À/À MEFs grown at $80% confluency were co-transfected with HttQ72-CFP and HA-p62. 24 hr after the transfection, cells were washed three times with PBS. The assay was performed according to the instructions of the manufacturer (Life Technologies, #L-3224).
Immunocytochemistry and Fluorescence Microscopy
Cells were grown on glass coverslips prior to transfection with plasmid constructs. 24 hr after the transfection, cells were washed three times with PBS, fixed in 4% paraformaldehyde (PFA) for 10 min, and permeabilized with 0.1% Triton X-100 in PBS for 10 min. After washing three times with PBS, cells were blocked with 2% BSA in PBS for 30 min to 1 hr at room temperature (RT). Cells were stained with primary antibody at 4 C overnight, followed by three washes with PBS. Cells were incubated with Alexa Fluor 555-or 488-conjugated secondary antibody at RT for 1 hr and mounted with Mowiol medium containing DAPI. 10 random fields were taken with a 203 objective in a Nikon Eclipse 80i fluorescence microscope. Co-transfected cells were counted as the total number of cells, and cells containing ubiquitin-positive aggregates were counted using ImageJ software (NIH). The images are presented in pseudo-color. For the CherryeGFP-p62 assay, p62 À/À MEFs were transfected with Cherry-eGFP-p62-WT, K420R, or T350A with or without Myc-Keap1/V5-Cul3 for 24 hr. Cells were washed twice with PBS and mounted with Mowiol medium containing DAPI without fixation to avoid pH disruption (Goode et al., 2016a) . Pearson's coefficient between the red and green channel was measured by ImageJ.
FRAP p62 À/À MEFs were grown on 1.5 glass-bottom 35-mm dishes (MatTek, #P35G-1.5-10-C) and transfected with pDest-mCherry-p62 for 24 hr prior to imaging. Immediately before imaging, the medium was replaced with phenol red-free medium (Gibco, #21063029) containing 10% fetal bovine serum (FBS), 50 mg/mL penicillin-streptomycin (P/S), 1% sodium pyruvate, and 1% non-essential amino acids. The live cell samples were placed on a heated chamber at 37 C with 5% CO 2 . Imaging and photobleaching were performed with a 403 oil objective using a Nikon A1Rsi confocal microscope. Before bleaching, images of pre-bleached p62 bodies were taken. A 561-nm laser was used to photobleach p62 bodies for 500 ms. Immediately after the bleaching, the images were collected every 2 s for a total of 5 min as a post-bleach sample. The fluorescence intensities of postbleached p62 bodies were individually measured. In the meantime, the fluorescence intensities of non-bleached p62 bodies were measured as a control. An average of p62 bodies in different cells (n R 7 cells containing p62 bodies) was calculated. The relative florescence intensities were calculated as the average fluorescence intensities of photobleached p62 bodies divided by the average fluorescence intensities of pre-bleached samples.
Cycloheximide Assay Keap1 À/À or control MEFs were transfected at $80% confluency with empty vector or Myc-Keap1/V5-Cul3. 24 hr after transfection, cells were treated with 10 mg/mL cycloheximide for varying times. 
Statistical Analysis

